Ajanta Pharma approves vesting of 4,300 cash‑settled SARs and cancels 800 ESOPs under SBIP 2019; cash settlement based on Feb 2, 2026 closing price; no equity issuance or dilution expected.
AI Assistant
Ajanta Pharma Ltd
2026
Announcement
Find Answers
Ask about any part of the document to get insights, explanations, or key details.